Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 17.51 M17.72 M16.99 M16.08 M 68.3 M Research & development ———— — Operating income 13.59 M12.38 M14.98 M12.04 M 52.99 M Non-Operating Income, Total 137 K5.76 M-47 K-42 K 5.81 M Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses 367 K6.08 M285 K-5.02 M 1.71 M Unusual income/expense -230 K-314 K-332 K4.97 M 4.1 M Pretax income 13.72 M18.14 M14.93 M12 M 58.8 M Equity in earnings ———— — Taxes 3.84 M4.99 M4.11 M3.15 M 16.09 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 9.88 M13.15 M10.83 M8.85 M 42.71 M Discontinued operations ———— — Net income 9.88 M13.15 M10.83 M8.85 M 42.71 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 9.88 M13.15 M10.83 M8.85 M 42.71 M Basic earnings per share (Basic EPS) 0.390.510.430.34 1.67 Diluted earnings per share (Diluted EPS) 0.390.510.420.35 1.67 Average basic shares outstanding 25.36 M25.72 M25.44 M25.61 M — Diluted shares outstanding 25.52 M25.79 M25.53 M25.69 M — EBITDA 15.64 M19.93 M17.21 M14.16 M 66.94 M EBIT 11.4 M15.65 M12.96 M3.81 M 43.82 M Cost of revenue 67.53 M68.57 M68.22 M68.24 M 272.56 M Other cost of goods sold ———— — Depreciation & amortization (cash flow) 4.24 M4.28 M4.26 M10.35 M 23.13 M